7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Innovative Nanoformulation of Antimicrobial Peptides to Treat Bacterial Infectious Diseases (FORMAMP)
Date du début: 1 déc. 2013, Date de fin: 30 nov. 2017,
Resistance to traditional antibiotics is a rapidly increasing problem that in a few years could make infections impossible to treat and bring the state of medical care back to the pre-antibiotic era from the beginning of the last century. Antimicrobial peptides (AMPs) have a huge potential as new therapeutics against infectious diseases as they are less prone to induce resistance due to their fast ...
Voir le projet
18
Participants partenaires
TERMINÉ
European Research Infrastructures for Poverty Related Diseases (EURIPRED)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,
...highly successful model of the Centre for AIDS Reagents (CFAR), a twenty-three year old reagent initiative based at the National Institute of Biological Standards and Control (NIBSC), a centre of the Medical Healthcare Products Regulatory Authority Agency (MHRA) and will comprise of a world-class team of experts and repositories with expertise in vaccine, microbicide and drug development for a ran ...
Voir le projet
18
Participants partenaires
TERMINÉ
Oral biopharmaceutics tools (ORBITO)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2017,
The OrBiTo project will deliver novel methods and a framework for rational application of predictive biopharmaceutics tools for oral drug delivery. This will be achieved through novel propsective studies to define new methodlogies which will be validated using historical datasets from EFPIA partners. A combination of high quality in vitro or in silico characterizations of API and formulations will ...
Voir le projet
28
Participants partenaires
TERMINÉ
Recognising Adverse Drug Reactions (WEB-RADR)
Date du début: 1 sept. 2014, Date de fin: 31 août 2017,
...of the two projects. The MHRA has extensive experience in managing successful pharmacovigilance and IT projects (E2B compliant web-forms for ADR reporting; integration with EudraVigilance; drug and medical dictionary mapping; integration with NHS electronic health records) as well as being a leading regulatory agency, helping to shape the current legislative framework.Establishing clear policies a ...
Voir le projet
20
Participants partenaires
TERMINÉ
Make the Baltic Sea Region a lead in sustainable development for pharmaceuticals within EU
Date du début: 31 déc. 2012, Date de fin: 30 déc. 2014,
...ning the use and management of medicinal products by establishing a network with the focus on sustainable development. Good practices and experience will be exchanged between people with knowledge of medical products, health and environmental aspects within the region. Focal points should be established in all Baltic Sea region member states in order to increase knowledge and to provide a platform ...
Voir le projet
1
Participant partenaire
TERMINÉ
Embryonic Stem cell-based Novel Alternative Testing Strategies (ESNATS)
Date du début: 1 avr. 2008, Date de fin: 30 sept. 2013,
"ESNATS aims at developing a novel toxicity test platform based on embryonic stem cells (ESC), especially human ESC (hESC), to accelerate drug development, reduce R&D costs and propose a powerful alternative to animal tests (3 Rs). ESNATS will address current drug-testing shortcomings: - testing takes place late in the development cycle - animal test systems bear the risk of non-prediction due to ...
Voir le projet
34
Participants partenaires
TERMINÉ
Optimizing drug safety monitoring to enhance patient safety and achieve better health outcomes (Monitoring medicines)
Date du début: 1 sept. 2009, Date de fin: 31 juil. 2013,
"Medicines are one of the most common health interventions. Expenditure on pharmaceuticals range from 10–20 % of all health expenditure in rich countries & from 20–60 % in poor countries. Knowledge of appropriate & safe medicines has grown. But the incidence of medicines adverse effects remains high. In a UK study 6.5% of hospitals admissions were related to an adverse drug reaction (ADR). And as ...
Voir le projet